84-1180-14 LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) 100ul L4502-20P

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s, is a progressive movement disorder characterized by rigidity, tremors and postural instability.
  • The pathological hallmark of PD is progressive loss of dopaminergic neurons in thesubstantia nigra of the ventral midbrain and the presence of intracellular Lewy bodies (protein aggregates of a-synuclein, ubiquitin and other components) in surviving neurons of the brain stem (1).
  • Various genes and loci (a-synuclein/PARK1 and 4, parkin/PARK2, UCH-L1/PARK5,PINK1/PARK6, DJ-1/PARK7, LRRK2/PARK8, synphilin-1 and NR4A2) are genetically linked to PD (2).
  • Leucine-rich repeat kinase 2 (LRRK2) contains amino-terminal leucine-rich repeats (LRR), a Ras-like small GTP binding protein-like (ROC) domain, a MLK protein kinase domain and carboxy-terminal WD40-repeat.
  • At least 20 LRRK2 mutations have been linked to PD, the G2019S mutation being the most prevalent (3).
  • The G2019S mutation causes increased LRRK2 kinase activity, which induces a progressive reduction in neurite length, leading to progressiveneurite loss and decreased neuronal survival (4).
  • The MLK inhibitor CEP-1347 is explored in PD clinical trials indicating that LRRK2 may have value as a therapeutic target for treatment of PD (5).
  • Applications:Suitable for use in Western Blot and Immunoprecipitation.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:1000, incubate membrane with diluted antibody in 5% BSA, 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking, overnight
  • Immunoprecipitation: 1:50Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for at least 12 months.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A and peptide affinity chromatography.
  • Form:Supplied as a liquid in 10mM sodium HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol.
  • Specificity:Recognizes endogenous levels of total human LRRK2. Species Crossreactivity: mouse, rat.
  • Isotype:IgG
  • Calc Applications Abbrev:IP WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Synthetic peptide corresponding to residues surrounding Leu1848 of human LRRK2.
  • Shelf Life:1year
  • Swiss Prot Number:Q5S007
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1180-14
型番
L4502-20P
入り数
1個
標準価格
176,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:点

お買い物を続ける カートを見る